Trial Profile
PREQUEL study- Prevention after ECT with Quetiapine extended release of Lowered Mood (in remitted Major Depressive Disorder following ECT)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Antidepressants
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PREQUEL
- 04 Mar 2014 Status changed from not yet recruiting to discontinued as reported by Australian & NZ Clinical Trials Register.
- 22 Jul 2011 New trial record